CASE REPORTAn 87-year-old man was initially hospitalized in the FrancoVietnamese Hospital in Ho Chi Minh City in Vietnam for abdominal pain, fever, chills and anorexia. Laboratory examination showed a leukocyte count of 20,900 cells/mm 3 90% neutrophiles. The C-reactive protein level was 170 mg/L and results of hepatic tests were abnormal with elevated levels of liver enzymes (alkaline phosphatase and γ-glutamyltransferase) 15-fold higher than normal values. A computed tomography (CT) scan of the abdomen showed many focal hepatic lesions.On initial aspiration of the abdominal lesions, 300 mL of brown fluid was obtained, followed by another 150 mL. Pus was sterile, but the amebic serologic results were positive (agglutination and enzyme-linked immunosorbent assay; Biotrin International, Dublin, Ireland). He was treated with metronidazole, 500 mg, three times a day, and ofloxacin, 200 mg twice a day, for five days and then only metronidazole for a week.Because of persistent hepatic pain, he was referred to our infectious and tropical diseases unit in France. The patient was afebrile and had a tender right upper quadrant of the liver, subconjunctival jaundice, and bilateral lower limb pitting edema without any portal hypertension signs. He had a weight gain of 4 kg. A chest radiograph showed pleural effusion, and a contrast abdominal CT scan showed a hypodense filling defect, suggestive of thrombus in the median hepatic vein, after the hepatic and portal venous phase ( Figure 1 ).Congenital and acquired thrombophilia tests were conducted. These tests included autoimmune investigations and a screening for protein C or S deficiency, Factor II, Factor V Leiden gene mutations, myeloproliferative diseases, antiphospholipid syndrome, and hyperhomocysteinemia. All test results were negative. In addition, there were no underlying comorbidities that could facilitate venous thrombosis.Progressive recovery was seen after therapeutic anticoagulation by low molecular weight heparin (enoxaparine) given concomitantly with a vitamin K antagonist (fluindione) for three days and then fluindione alone for six months. The patient also received metronidazole, 500 mg three times a day for 3 days to complete the 14-day therapy initiated in Vietnam. Re-evaluation with an abdominal CT scan six months later showed partial regression of hepatic lesions and total regression of the thrombus.The worldwide incidence of symptomatic amebiasis (colitis and liver abscess) is estimated to be approximately 50 million cases annually, with liver abscess in perhaps 1% of the cases.
1The causative protozoan parasite, Entamoeba histolytica , is a virulent pathogen. Trophozoites of E. histolytica invade the intestinal mucosa, causing amebic colitis, and can breach the mucosal barrier and travel through the portal circulation to the liver.1 Amebic liver abscess is the most common extraintestinal manifestation of amebiasis, and is often characterized by a painful and enlarged liver associated with fever. This abscess consists of a few E. histolytica trophozoi...